Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$655M |
| 2 |
Coty
COTY
|
+$380M |
| 3 |
ConocoPhillips
COP
|
+$250M |
| 4 |
Zimmer Biomet
ZBH
|
+$213M |
| 5 |
Valero Energy
VLO
|
+$170M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$523M |
| 2 |
Merck
MRK
|
+$375M |
| 3 |
SHPG
Shire pic
SHPG
|
+$362M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$310M |
| 5 |
CELG
Celgene Corp
CELG
|
+$286M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.57% |
| 2 | Technology | 12.05% |
| 3 | Financials | 10.74% |
| 4 | Consumer Discretionary | 9.44% |
| 5 | Energy | 8.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1751
Evolent Health
EVH
$553M
| $4.93M | 0.01% |
392,266
-1,638,549
| -81% | -$25.9M |
|
|
ATCX
1752
DELISTED
Atlas Technical Consultants, Inc. Class A Common Stock
ATCX
| $4.93M | 0.01% |
+507,614
| New | +$4.94M |
|
1753
CALL
Royal Caribbean
RCL
$78.2B
| $4.93M | 0.01% |
+43,000
| New | +$4.89M |
|
1754
Tennant Co
TNC
$1.19B
| $4.91M | 0.01% |
79,120
+10,891
| +16% | +$652K |
|
|
STR
1755
DELISTED
Sitio Royalties
STR
| $4.91M | 0.01% |
138,827
-257,029
| -65% | -$8.41M |
|
1756
iShares Core S&P Small-Cap ETF
IJR
$111B
| $4.9M | 0.01% |
63,555
+14,355
| +29% | +$1.1M |
|
|
ORTX
1757
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
| $4.9M | 0.01% |
27,421
-1,532
| -5% | -$230K |
|
1758
Travere Therapeutics
TVTX
$6.32B
| $4.9M | 0.01% |
216,633
-74,827
| -26% | -$1.65M |
|
|
PMT
1759
PennyMac Mortgage Investment
PMT
$810M
| $4.9M | 0.01% |
236,572
+170,723
| +259% | +$3.44M |
|
|
BZUN
1760
Baozun
BZUN
$165M
| $4.9M | 0.01% |
117,910
-56,005
| -32% | -$1.96M |
|
1761
CALL
Expedia Group
EXPE
$40.6B
| $4.89M | 0.01% |
41,100
-8,300
| -17% | -$1.01M |
|
1762
CALL
B&G Foods
BGS
$286M
| $4.88M | 0.01% |
+200,000
| New | +$5.24M |
|
|
TDAY
1763
USA Today Co
TDAY
$953M
| $4.88M | 0.01% |
464,684
-153,227
| -25% | -$1.96M |
|
|
SEMG
1764
DELISTED
SEMGROUP CORPORATION
SEMG
| $4.86M | 0.01% |
329,731
-241,766
| -42% | -$3.82M |
|
1765
Ducommun
DCO
$2.74B
| $4.84M | 0.01% |
111,320
+90,923
| +446% | +$3.73M |
|
1766
Sonos
SONO
$1.81B
| $4.84M | 0.01% |
470,433
+429,120
| +1,039% | +$4.65M |
|
1767
Littelfuse
LFUS
$10.3B
| $4.84M | 0.01% |
26,521
-38,707
| -59% | -$7.15M |
|
|
ALDR
1768
DELISTED
Alder Biopharmaceuticals
ALDR
| $4.84M | 0.01% |
354,469
-122,841
| -26% | -$1.59M |
|
1769
Upbound Group
UPBD
$1.13B
| $4.83M | 0.01% |
231,229
-1,154,148
| -83% | -$21.3M |
|
1770
CALL
Cardinal Health
CAH
$55.3B
| $4.82M | 0.01% |
100,000
+25,000
| +33% | +$1.25M |
|
|
ELLI
1771
DELISTED
Ellie Mae Inc
ELLI
| $4.81M | 0.01% |
+48,726
| New | +$4.23M |
|
1772
Invesco
IVZ
$14.4B
| $4.8M | 0.01% |
248,456
+193,623
| +353% | +$3.62M |
|
1773
BCE
BCE
$22B
| $4.79M | 0.01% |
107,818
-33,003
| -23% | -$1.42M |
|
1774
National Fuel Gas
NFG
$7.81B
| $4.79M | 0.01% |
78,488
+74,043
| +1,666% | +$4.3M |
|
1775
AZZ Inc
AZZ
$4.16B
| $4.78M | 0.01% |
116,752
+44,288
| +61% | +$1.96M |
|
Similar funds
Israel Englander's Q1 2019 Portfolio in Review
As of Q1 2019, Israel Englander held 4,608 positions worth $66.8B, up 4.2% from $64.1B the previous quarter. Its ten largest holdings account for 7.1% of the portfolio.
Israel Englander withdrew a net $6.14B in Q1 2019, closing 675 positions and reducing 1,467 holdings. Its most notable exit was Merck, an estimated $375M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, down from 14% a quarter earlier, followed by Technology and Financials.
Against the trend, Israel Englander opened a new position in Zimmer Biomet worth $232M.
- Israel Englander's largest Q1 2019 buy was Zimmer Biomet: 1,870,503 shares worth $232M.
- Israel Englander added most to Walt Disney in Q1 2019, an estimated $655M increase.
- Israel Englander's biggest Q1 2019 reduction was Apple, cutting an estimated $523M.
- Israel Englander fully exited Merck in Q1 2019, selling an estimated $375M.
- Israel Englander's ten largest holdings make up 7.1% of its $66.8B portfolio in Q1 2019.
- Israel Englander opened 914 new positions and closed 675 in Q1 2019.
- Israel Englander's portfolio value rose 4.2% quarter-over-quarter to $66.8B.
Based on Millennium Management's 13F filing for Q1 2019, filed 14 May 2019.